Featured Post

Latest Gold News

Economic power could shift further East with Hong Kong gold exchange Russian investment bank sees $1,400 gold by end of 2017 Weak CPI...

Tuesday, December 13, 2011

Nexen (NXY) (NXTM) (ONXX) (APC) (ARIA) (ARRY) Ratings Reiterated

Nexen Inc. (NYSE: NXY), Nxstage Medical (NASDAQ: NXTM), Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), Anadarko Petroleum (NYSE: APC), Ariad Pharmaceutical (NASDAQ: ARIA) and Array Biopharma Incorporated (NASDAQ: ARRY) had ratings on them reiterated by analysts.

Canaccord Genuity reiterated its "Buy" rating on Nxstage Medical (NXTM).

Citigroup (NYSE:C) reiterated its "Buy" rating on Nexen Inc. (NXY). They have a price target of $20.00 on the company.

JPMorgan Chase & Co. (NYSE:JPM) reiterated its "Overweight" rating on Onyx Pharmaceuticals, Inc. (ONXX).

Citigroup reiterated its "Buy" rating on Anadarko Petroleum (APC). They have a price target of $120.00 on the company.

Jefferies (NYSE:JEF) reiterated its "Buy" rating on Ariad Pharmaceutical (ARIA).

Jefferies reiterated its "Buy" rating on Array Biopharma Incorporated (ARRY). They have a price target of $6.00 on the company.

No comments: